Drug information provided by: Merative, Micromedex®
Olutasidenib is used to treat acute myeloid leukemia in patients with a susceptible isocitrate dehydrogenase-1 (IDH-1) mutation that has come back or has not improved after previous treatments. Your doctor will test for the presence of this mutation.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.